Sakai, Japan

Shunji Kozaki



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Shunji Kozaki**

Introduction

Shunji Kozaki, an accomplished inventor based in Sakai, Japan, has made significant advancements in the field of biotechnology. With a total of two patents to his name, Kozaki is recognized for his contributions to the treatment of botulism and the development of innovative therapeutic methods involving botulinum toxin preparations.

Latest Patents

Kozaki's latest patents include a method for treating patients with neutralizing antibodies to a type A1 botulinum toxin. This method, centered around the use of a 150 kDa type A neurotoxin from type A2 (A2 NTX), addresses the clinical challenges faced by patients who experience decreased responses due to previous treatments with type A1 botulinum toxin. Additionally, he has developed a composition for neutralizing botulinum toxin type A, which comprises a combination of human anti-botulinum toxin type A antibodies. This composition is designed to effectively combat botulism diseases, showcasing high neutralizing activity through the use of multiple antibodies with different epitopes.

Career Highlights

Throughout his career, Shunji Kozaki has collaborated with notable institutions such as the Chemo-Sero-Therapeutic Research Institute and the Institute for Antibodies Co., Ltd. His work in these organizations has allowed him to further his research and development in the field of immunology and toxin neutralization, spearheading innovative solutions for health challenges.

Collaborations

Kozaki has partnered with talented coworkers, including Shinji Nakahira and Yasushi Torii, contributing to a collaborative environment that fosters innovation. Together, they have advanced research and expanded the understanding of botulinum toxins and their therapeutic applications.

Conclusion

Shunji Kozaki's innovative work in the realm of biotechnology and botulinum toxin research has paved the way for new therapeutic methods and compositions that hold promise for the treatment of botulism and related conditions. His contributions continue to influence the field, demonstrating the importance of continuous research and collaboration in delivering effective healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…